QA: MERIDIAN BIOSCIENCE INC in us_medicinal_products/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000794172_2021_MERIDIAN_BIOSCIENCE_INC.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3434006467793886, 'aggregate_val': 405261000, 'exp_sum': 617212000, 'exp_to_value': {'AssetsCurrent': 162190000, 'AssetsNoncurrent': 211951000, 'PropertyPlantAndEquipmentNet': 31120000, 'Goodwill': 197383000, 'remainder_Assets': 14568000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.02356351743105627, 'aggregate_val': 157632000, 'exp_sum': 161436000, 'exp_to_value': {'LiabilitiesNoncurrent': 105108000, 'LiabilitiesCurrent': 56328000, 'remainder_Liabilities': 0}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000794172, MERIDIAN BIOSCIENCE INC

  xvar xval
0 LiabilitiesNoncurrent 105,108,000
1 LiabilitiesCurrent 56,328,000
2 remainder_Liabilities -3,804,000
3 AssetsCurrent 162,190,000
4 AssetsNoncurrent 211,951,000
5 PropertyPlantAndEquipmentNet 31,120,000
6 Goodwill 197,383,000
7 remainder_Assets -197,383,000
8 GeneralAndAdministrativeExpense 168,250,000
9 ResearchAndDevelopmentExpense 23,729,000
10 remainder_Expenses 13,471,000
11 remainder_Revenues 253,667,000
12 remainder_NetIncome -2,031,000
13 remainder_ComprehensiveNetIncome 3,115,000
  yvar yval
0 Liabilities 157,632,000
1 Assets 405,261,000
2 Expenses 205,450,000
3 Revenues 253,667,000
4 StockholdersEquity 247,629,000
5 NetIncome 46,186,000
6 ComprehensiveNetIncome 47,743,500
7 BaseVar 513,578,000
8 EconomicCapitalRatio 0.918

Edgar->Model Mapping

Feature Distribution

Change over Time